Showing results (191-200 of 211) with videos related to
Sort By:
Pageof 22
Database : the Journal of Biological Databases and Curation|January 25, 2020
Human Breathomics DatabaseTien-Chueh Kuo, Cheng-En Tan, San-Yuan Wang, et al.Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.Oncology|October 1, 2023
Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsDerek De-Rui Huang, Bin-Chi Liao, Wei-Hsun Hsu, et al.Cell Reports|January 12, 2025
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcomaEnrico Pozzo, Laura Yedigaryan, Nefele Giarratana, et al.Theranostics|October 14, 2021
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblastsPei-Jung Lee, Chao-Chi Ho, Hao Ho, et al.Journal of Cancer|May 29, 2018
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in TaiwanShu-Yung Lin, Ching-Yao Yang, Bin-Chi Liao, et al.Cancer Research|March 27, 2021
Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CADHsin-Fang Tu, Chun-Jung Ko, Ching-Tai Lee, et al.Shock (Augusta, Ga.)|February 19, 2015
Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsisKuei-Pin Chung, Hou-Tai Chang, Shyh-Chyi Lo, et al.European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitorsChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.The Oncologist|May 10, 2020
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving CrizotinibChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.Pageof 22